Table of Contents

May/June 2000; Volume 54,Issue 3

B

  1. Beijnen, J. H.

    1. Pharmaceutical Development of a Parenteral Lyophilized Formulation of the Novel Antitumor Agent Aplidine
      B. Nuijen, M. Bouma, R. E. C. Henrar, P. Floriano, J. M. Jimeno, H. Talsma, J. J. Kettenes-van den Bosch, A. J. R. Heck, A. Bult and J. H. Beijnen
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 193-208;

  2. Bhardwaj, Renu

    1. Approaches to Reducing Toxicity of Parenteral Anticancer Drug Formulations Using Cyclodextrins
      Renu Bhardwaj, Robert T. Dorr and James Blanchard
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 233-239;

  3. Blanchard, James

    1. Approaches to Reducing Toxicity of Parenteral Anticancer Drug Formulations Using Cyclodextrins
      Renu Bhardwaj, Robert T. Dorr and James Blanchard
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 233-239;

  4. Bouma, M.

    1. Pharmaceutical Development of a Parenteral Lyophilized Formulation of the Novel Antitumor Agent Aplidine
      B. Nuijen, M. Bouma, R. E. C. Henrar, P. Floriano, J. M. Jimeno, H. Talsma, J. J. Kettenes-van den Bosch, A. J. R. Heck, A. Bult and J. H. Beijnen
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 193-208;

  5. Bruttin, Frances

    1. Risk and the Economics of Regulatory Compliance
      Doug Dean and Frances Bruttin
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 253-263;

  6. Bult, A.

    1. Pharmaceutical Development of a Parenteral Lyophilized Formulation of the Novel Antitumor Agent Aplidine
      B. Nuijen, M. Bouma, R. E. C. Henrar, P. Floriano, J. M. Jimeno, H. Talsma, J. J. Kettenes-van den Bosch, A. J. R. Heck, A. Bult and J. H. Beijnen
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 193-208;

C

  1. Cundell, Anthony M.

    1. A Comparison of the MicroCount™ Digital System to Plate Count and Membrane Filtration Methods for the Enumeration of Microorganisms in Water for Pharmaceutical Purposes
      Gerald Marino, Christoph Maier and Anthony M. Cundell
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 172-192;

D

  1. Dean, Doug

    1. Risk and the Economics of Regulatory Compliance
      Doug Dean and Frances Bruttin
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 253-263;

  2. Dorr, Robert T.

    1. Approaches to Reducing Toxicity of Parenteral Anticancer Drug Formulations Using Cyclodextrins
      Renu Bhardwaj, Robert T. Dorr and James Blanchard
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 233-239;

F

  1. Floriano, P.

    1. Pharmaceutical Development of a Parenteral Lyophilized Formulation of the Novel Antitumor Agent Aplidine
      B. Nuijen, M. Bouma, R. E. C. Henrar, P. Floriano, J. M. Jimeno, H. Talsma, J. J. Kettenes-van den Bosch, A. J. R. Heck, A. Bult and J. H. Beijnen
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 193-208;

H

  1. Halls, Nigel A.

    1. Practicalities of Setting Acceptance Criteria for Media Fill Trials
      Nigel A. Halls
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 247-252;

  2. Heck, A. J. R.

    1. Pharmaceutical Development of a Parenteral Lyophilized Formulation of the Novel Antitumor Agent Aplidine
      B. Nuijen, M. Bouma, R. E. C. Henrar, P. Floriano, J. M. Jimeno, H. Talsma, J. J. Kettenes-van den Bosch, A. J. R. Heck, A. Bult and J. H. Beijnen
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 193-208;

  3. Henrar, R. E. C.

    1. Pharmaceutical Development of a Parenteral Lyophilized Formulation of the Novel Antitumor Agent Aplidine
      B. Nuijen, M. Bouma, R. E. C. Henrar, P. Floriano, J. M. Jimeno, H. Talsma, J. J. Kettenes-van den Bosch, A. J. R. Heck, A. Bult and J. H. Beijnen
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 193-208;

J

  1. Jimeno, J. M.

    1. Pharmaceutical Development of a Parenteral Lyophilized Formulation of the Novel Antitumor Agent Aplidine
      B. Nuijen, M. Bouma, R. E. C. Henrar, P. Floriano, J. M. Jimeno, H. Talsma, J. J. Kettenes-van den Bosch, A. J. R. Heck, A. Bult and J. H. Beijnen
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 193-208;

K

  1. Kettenes-van den Bosch, J. J.

    1. Pharmaceutical Development of a Parenteral Lyophilized Formulation of the Novel Antitumor Agent Aplidine
      B. Nuijen, M. Bouma, R. E. C. Henrar, P. Floriano, J. M. Jimeno, H. Talsma, J. J. Kettenes-van den Bosch, A. J. R. Heck, A. Bult and J. H. Beijnen
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 193-208;

  2. Knapp, Julius Z.

    1. Origin, Result and Measurement of USP “Essentially Free” Inspection for Visible Contaminating Particles
      Julius Z. Knapp
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 218-232;

  3. Kosary, P.

    1. Mixed Micelle Proliposomes for Preparation of Liposomes Containing Amphotericin B, In-vitro and Ex-vivo Studies
      M.N. Sarbolouki, S. Parsaee and P. Kosary
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 240-246;

L

  1. Lawrence, Stephen A.

    1. β-Propiolactone: Viral Inactivation in Vaccines and Plasma Products
      Stephen A. Lawrence
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 209-217;

M

  1. Maier, Christoph

    1. A Comparison of the MicroCount™ Digital System to Plate Count and Membrane Filtration Methods for the Enumeration of Microorganisms in Water for Pharmaceutical Purposes
      Gerald Marino, Christoph Maier and Anthony M. Cundell
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 172-192;

  2. Marino, Gerald

    1. A Comparison of the MicroCount™ Digital System to Plate Count and Membrane Filtration Methods for the Enumeration of Microorganisms in Water for Pharmaceutical Purposes
      Gerald Marino, Christoph Maier and Anthony M. Cundell
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 172-192;

N

  1. Nuijen, B.

    1. Pharmaceutical Development of a Parenteral Lyophilized Formulation of the Novel Antitumor Agent Aplidine
      B. Nuijen, M. Bouma, R. E. C. Henrar, P. Floriano, J. M. Jimeno, H. Talsma, J. J. Kettenes-van den Bosch, A. J. R. Heck, A. Bult and J. H. Beijnen
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 193-208;

P

  1. Parsaee, S.

    1. Mixed Micelle Proliposomes for Preparation of Liposomes Containing Amphotericin B, In-vitro and Ex-vivo Studies
      M.N. Sarbolouki, S. Parsaee and P. Kosary
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 240-246;

S

  1. Sarbolouki, M.N.

    1. Mixed Micelle Proliposomes for Preparation of Liposomes Containing Amphotericin B, In-vitro and Ex-vivo Studies
      M.N. Sarbolouki, S. Parsaee and P. Kosary
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 240-246;

T

  1. Talsma, H.

    1. Pharmaceutical Development of a Parenteral Lyophilized Formulation of the Novel Antitumor Agent Aplidine
      B. Nuijen, M. Bouma, R. E. C. Henrar, P. Floriano, J. M. Jimeno, H. Talsma, J. J. Kettenes-van den Bosch, A. J. R. Heck, A. Bult and J. H. Beijnen
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 193-208;

W

  1. Wekhof, Alexander

    1. Disinfection with Flash Lamps
      Alexander Wekhof
      PDA Journal of Pharmaceutical Science and Technology May 2000, 54 (3) 264-276;
Back to top

In This Issue